ClinicalTrials.gg
RecruitingNCT07316816Updated Jan 5, 2026

Stanford Pediatric Healthy Weight Index

An interventional study of Remote Monitoring Program in Obesity & Overweight, sponsored by Stanford University. Recruiting at 1 site in United States. Open to participants aged 10 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-01-05.

Sponsored by Stanford University · Not applicable, Interventional, and Diagnostic

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Non-randomized
Ages
10 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 61 studies in Obesity by Stanford University — 8 open to participants now, 10 under way, none of them phase 3. Obesity · Stanford University.

Planned enrollment
25th of 53
120 · median 102
Started
2026
with 2 others
No phase
42 of 61
6 open now
Registered
59th of 61
by date

Among the 61 studies in Obesity by Stanford University, this one is the 25th largest by planned enrollment of the 53 interventional ones that give a count, is one of 3 that started in 2026, is one of 42 with no phase, and was the 59th registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

8 of the 61 studies in Obesity by Stanford University are open now, in 1 country. Recruiting first, the newest first:

2 more — sign in →

By country, each count listing its studies:

All 8 open studies →

Where they have run

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 10 Years to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 61 studies in Obesity by Stanford University, or all of them as a file.
02

Study summary

This study will develop a simple index to measure how well the body uses insulin and overall heart and metabolic health in children and teens with obesity. The investigators will use data from wearable devices (like fitness trackers) and glucose monitors, along with lab tests, to learn how activity and glucose relate to metabolic problems.

Read the detailed description

This is a prospective cohort study to develop a metabolic index for insulin sensitivity and cardiometabolic fitness among children and adolescents with obesity. Adolescent patients undergoing evaluation for bariatric surgery or medical management of wight using GLP-1 agonist therapies will be consented for participation. Participants will be given a wearable fitness device and a continuous glucose monitor. Continuous monitoring will be carried out at three time points: preoperative or prior to starting medication, perioperative or after 3-4 weeks of GLP1 use during early treatment phase, and 3 months post-operatively or 3 months after dose stabilization or discontinuation.

03

Conditions studied

  • Obesity & Overweight

Keywords

  • Metabolism
  • Continuous Glucose Monitoring
  • Obesity
  • Bariatric Surgery
  • GLP-1
04

Who can participate

Ages eligible
10 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Class 2 and 3 obesity
  • Patient in the Adolescent Bariatric Program at Stanford Children's that is eligible for either laparoscopic sleeve gastrectomy or GLP1 Receptor Agonist Therapy
  • Willingness to wear a CGM and physiological monitor for the duration of the study.

Exclusion criteria

Exclusion Criteria:

  • Hypothalamic and syndromic obesity
  • > 55
  • Plan to undergo bariatric surgical procedure other than sleeve gastrectomy
  • Prior bariatric surgical procedure
  • Active GLP treatment (within past 3 months)
  • Unable to read, understand, or complete the in English or Spanish
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    Bariatric Surgery

    Adolescent patients in the Adolescent Bariatric Program at Stanford Children's undergoing bariatric surgery will undergo continuous glucose monitoring and fitness tracking throughout the course of study.

    Other: Remote Monitoring Program

  • Experimental
    GLP-1

    Adolescent patients being considered for GLP-1 receptor agonist therapy for obesity management will undergo continuous glucose monitoring and fitness tracking throughout the course of study.

    Other: Remote Monitoring Program

Interventions

  • OtherRemote Monitoring Program

    Continuous glucose monitors will be placed at 2 or 3 clinically relevant time points and participants will track their fitness using wearable devices.

06

What researchers measure

Primary outcomes

  1. Percent Reduction in BMI

    assessment of change in BMI from pre-intervention to post-intervention

    Time frame: baseline through study completion, an average of 4 months

  2. Body Weight

    Change in body weight (kg)

    Time frame: baseline through study completion, an average of 4 months

  3. Fasting Glucose

    change in fasting glucose levels from pre-intervention to post-intervention

    Time frame: baseline through study completion, an average of 4 months

  4. Fasting Insulin

    change in fasting insulin levels from pre-intervention to post-intervention

    Time frame: baseline through study completion, an average of 4 months

  5. HbA1c

    change in HbA1c levels from pre-intervention to post-intervention

    Time frame: baseline through study completion, an average of 4 months

  6. Lipid Panel

    changes in lipid panel levels from pre-intervention to post-intervention

    Time frame: baseline through study completion, an average of 4 months

  7. Liver Enzymes

    changes in liver enzymes from pre-intervention to post-intervention

    Time frame: baseline through study completion, an average of 4 months

Secondary outcomes

  1. Obesity-related Comorbidities

    Defined as resolution or improvement according to prespecified clinical criteria

    Time frame: baseline through study completion, an average of 4 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2026; primary completion for Dec 2030, 59 months later.

Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 59 months is above that.

Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 8, 2025
First posted
Jan 5, 2026
StartEst.
Jan 5, 2026
Primary completionEst.
Dec 2030
CompletionEst.
Dec 2030
Last update
Jan 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07316816
Responsible party
Karl Sylvester (Professor of Surgery, Stanford University) — Principal investigator
First posted
Jan 5, 2026
Start date
Jan 5, 2026 (estimated)
Primary completion
Dec 2030 (estimated)
Completion
Dec 2030 (estimated)
Last update
Jan 5, 2026

Study contacts

Karl Sylvester, MD
Contact
karls@stanford.edu
650-723-6439

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion